Estudo randomizado | Adjuvante S-1 comparado com observação no câncer ressecado do trato biliar

Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial – The Lancet (link para o resumo – $ para o texto completo)

Comentário no Twitter

New @TheLancet – Nakachi et al – Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial https://t.co/E6y7a9dWNf#gitwitter #biliarytractcancer #onctwitter @OncoAlert #JCOG pic.twitter.com/WEBFXjIWce

— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) January 20, 2023